FDA.reportPublic FDA data

Risperdal 37.5 MG Injection

RxCUI
706827
RxNorm name
Risperdal 37.5 MG Injection
Display name
Risperdal 37.5 MG Injection
Full name
Risperdal 37.5 MG Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:18

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
RISPERDAL CONSTARISPERIDONEJanssen Pharmaceuticals, Inc.bb34ee82-d2c2-43b8-ba21-2825c09546912025-11-05Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 706827

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
bb34ee82-d2c2-43b8-ba21-2825c0954691RisperDAL CONSTA 37.5 MG Injection [PSN] · risperidone 37.5 MG Injection [Risperdal] [SBD] · Risperdal 37.5 MG Injection [SY]338These highlights do not include all the information needed to use RISPERDAL CONSTA ® safely and effectively. See full prescribing information for RISPERDAL CONSTA ® . . RISPERDAL CONSTA ® (risperidone) LONG-ACTING INJECTION Initial U.S. Approval: 200320251105